Get startedLog in
    Picture of Matinas BioPharma Holdings logo

    MTNB — Matinas BioPharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Patient With Candida Krusei Infection In Matinas Biopharma’S Oral Mat2203 Expanded Access Program Achieves Complete Clinical Resolution

    Picture of Matinas BioPharma Holdings logoMatinas BioPharma Holdings
    11/10/2023 12:35
    Oct 11 (Reuters) - Matinas BioPharma Holdings Inc
 MTNB.A :
    * PATIENT WITH CANDIDA KRUSEI INFECTION IN MATINAS
BIOPHARMA’S
ORAL MAT2203 EXPANDED ACCESS PROGRAM ACHIEVES COMPLETE CLINICAL
RESOLUTION

Source text for Eikon:  ID:nGNX7kcbC2 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com))

    Recent news on Matinas BioPharma Holdings

    See all news